South Korea’s 1st homegrown Covid-19 vaccine maker underlines global partnership
Seoul-based International Vaccine Institute, SK Bioscience, helped conduct the vaccine’s clinical trials across six countries, including Thailand and New Zealand.
Kan Hyeong-woo
Korea eyes world No. 3 spot in digital competitiveness by 2027
The government will also aim to complete setting up the infrastructure for a nationwide 5G network by 2024.
South Korea to spend 200 billion won for R&D digitalisation
The government will use the financial support for projects that integrate artificial intelligence and big data into developing diagnosis of diseases like dementia.
Google, Meta fined 100 billion won for illegal collection of personal data
According to an investigation, Google and Meta were found to have been collecting and analyzing users’ behavioral patterns without obtaining their consent.
‘Covid-19 is not over; people are still getting sick’: AstraZeneca official
The expert underlined the importance of continued efforts in innovating next-generation vaccines to prepare for a potential fight against new virus variants.
Scientists develop world’s 1st therapy for Charcot-Marie-Tooth disease
CMT disease, a group of inherited disorders that cause nerve damage, shows symptoms such as weakness in the legs and feet, loss of muscle bulk and curled toes.
Korea’s first domestic Covid-19 vaccine ready
As SKYCovione gets ready to reach the local market, some critics worry that it may draw a lukewarm reaction due to doubts over side effects.
South Korea’s ICT minister calls for caution on joining Chip 4
The science minister’s remarks come as tensions between the US and China have risen over Washington’s collective efforts to keep Beijing in check.
Korean companies rush to develop diagnostic kits for monkeypox
A number of firms that developed diagnostic kits for Covid-19 are involved.
Korea approves 1st homegrown Covid-19 vaccine
The government on June 29 announced the approval of SKYCovione, which has been authorised for two administrations with a four-week interval on people aged 18 or older.